(ADTX), Ardelyx (NASDAQ:ARDX) – 12 healthcare stocks move in Wednesday’s pre-market session

0

Winners

  • IsoPlexis (NASDAQ:ISO) shares rose 22.8% to $5.5 in Wednesday’s pre-market session. The company’s market cap is $214.2 million. The company’s fourth quarter results were released today.
  • Exicure (NASDAQ:XCUR) shares rose 21.48% to $0.26. The market value of their outstanding shares is $27.7 million.
  • Organogenesis funds (NASDAQ:ORGO) The stock rose 15.05% to $8.33. The market value of their outstanding shares is $1.0 billion. The company’s fourth quarter results were released yesterday.
  • Brickell Biotech (NASDAQ:BBI) The stock rose 12.59% to $0.24. The market value of their outstanding shares is $28.1 million.
  • Ardelyx (NASDAQ:ARDX) shares rose 11.95% to $0.81. The market value of their outstanding shares is $106.1 million. According to the press release, the fourth quarter results were released 2 days ago.
  • Aditxt (NASDAQ:ADTX) The stock rose 11.16% to $0.43. The market value of their outstanding shares is $18.9 million.

losers

  • Karyopharm Therapeutic (NASDAQ:KPTI) The stock was down 27.7% at $7.51 in Wednesday’s pre-market session. The market value of their outstanding shares is $568.8 million.
  • ChemoCentryx (NASDAQ:CCXI) The stock fell 13.41% to $25.51. The market value of their outstanding shares is $1.7 billion. According to the press release, fourth quarter results were released yesterday.
  • HOOKIPA Pharma (NASDAQ:HOOK) The stock fell 10.32% to $2.26. The market value of their outstanding shares is $70.7 million.
  • Inovio Pharmaceuticals (NASDAQ:INO) The stock fell 10.19% to $2.91. The company’s market cap is $612.2 million. The company’s fourth quarter results were released yesterday.
  • Intercept pharmaceuticals (NASDAQ:ICPT) The stock fell 9.0% to $13.65. The market value of their outstanding shares is $403.3 million. According to the news, the fourth quarter earnings report is out today.
  • Kodiak Science (NASDAQ:KOD) shares fell 7.58% to $8.17. The company’s market cap is $422.5 million. According to the press release, fourth quarter results were released yesterday. See also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Share.

Comments are closed.